AJMC July 19, 2024
Pearl Steinzor

Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School, discusses ways that wearable devices and health apps are improving value-based care.

Artificial intelligence (AI) is important to value-based care by contributing to better outcomes, patient adherence, and lowering costs, says Liz Kwo, MD, MBA, MPH, chief commercial officer, Everly Health, and faculty lecturer, Harvard Medical School.

This transcript has been lightly edited.

Transcript

Given the ongoing debate about AI’s role in clinical settings, how do you foresee the balance between AI and physician decision-making evolving in the context of value-based care?

When AI acts as an augmentative tool rather than a replacement for human expertise, that’s where this magic is made. So, decision...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Apps, Conferences / Podcast, Digital Health, Technology, Trends, Wearables
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review
Dexcom invests $75M in Ōura, agrees to integrate smart rings and CGMs
Wearable Device Can Warn of Worsening Heart Failure

Share This Article